Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition
Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Inclusion Criteria:
Exclusion Criteria:
global-roche-genentech-trials@gene.com888-662-6728 (U.S. and Canada)
Sherman Oaks, California 91403, United States
Columbus, Georgia 31904, United States
Chicago, Illinois 60640, United States
St Louis, Missouri 63110, United States
Springfield, New Jersey 07081, United States
C. A. B. A., C1055AAF, Argentina
Porto Alegre, Rio Grande do Sul 90610-000, Brazil
São Bernardo do Campo, São Paulo 09715-090, Brazil
Beijing, 100050, China
Shanghai, 200127, China
Meguro-Ku, 153-0051, Japan
Tokyo, 190-8531, Japan
?ory, 44-240, Poland
?ód?, 92-216, Poland
B?dzin, 42-500, Poland
Bia?ystok, 15-756, Poland
Gda?sk, 80-546, Poland
Gdansk, 80-214, Poland
Wroc?aw, 53-659, Poland
Zabrze, 41-800, Poland
Namdong-gu, 21565, South Korea
Donosti-San Sebastián, 20014, Spain
Kwei Shen, 33305, Taiwan
North Dist., 40447, Taiwan